Participant flow

Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma · Source last updated 2018-07-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Bendamustine is combined with standard chemotherapy

   id

   FG000

   title

   Bendamustine

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         3

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         3

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

There are no pre-assignment details to report

recruitment Details

Participants were recruited from May 2011 through April 2014 (36 months) from the Cardinal Bernardin Cancer Center at Loyola University Medical Center

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice